Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

[(18)F-FDG PET/CT in the evaluation of patients suspected of paraneoplastic neurological syndrome].

García Vicente AM, Vega Caicedo CH, Mondéjar Solís R, de Ayala Fernández JÁ, Garrido Robles JA, Pena Pardo FJ, Muñoz Pasadas M, Del Saz Saucedo P, Jiménez Londoño GA, León Martín A, Soriano Castrejón Á.

Rev Esp Med Nucl Imagen Mol. 2015 Jul-Aug;34(4):236-43. doi: 10.1016/j.remn.2015.02.006. Epub 2015 Apr 10. Spanish.

2.

Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes.

Vatankulu B, Yilmaz Aksoy S, Asa S, Sager S, Sayman HB, Halac M, Sonmezoglu K.

Rev Esp Med Nucl Imagen Mol. 2016 Jan-Feb;35(1):17-21. doi: 10.1016/j.remn.2015.07.001. Epub 2015 Aug 8.

3.

Utility of 18F-FDG-PET/CT in patients suspected of paraneoplastic neurological syndrome: importance of risk classification.

Pena Pardo FJ, García Vicente AM, Amo-Salas M, López-Fidalgo JF, Garrido Robles JA, de Ayala Fernández JÁ, Del Saz Saucedo P, Muñoz Pasadas M, Soriano Castrejón A.

Clin Transl Oncol. 2017 Jan;19(1):111-118. doi: 10.1007/s12094-016-1511-3. Epub 2016 May 2.

PMID:
27139696
4.

Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings.

Masangkay N, Basu S, Moghbel M, Kwee T, Alavi A.

Nucl Med Commun. 2014 Oct;35(10):1038-46. doi: 10.1097/MNM.0000000000000163.

PMID:
25023997
5.

Imaging Workup of Suspected Classical Paraneoplastic Neurological Syndromes: A Systematic Review and Retrospective Analysis of 18F-FDG-PET-CT.

Sundermann B, Schröder JB, Warnecke T, Heindel W, Schäfers M, Weckesser M, Buerke B.

Acad Radiol. 2017 Oct;24(10):1195-1202. doi: 10.1016/j.acra.2017.03.022. Epub 2017 May 24. Review.

PMID:
28551401
6.

FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.

Younes-Mhenni S, Janier MF, Cinotti L, Antoine JC, Tronc F, Cottin V, Ternamian PJ, Trouillas P, Honnorat J.

Brain. 2004 Oct;127(Pt 10):2331-8. Epub 2004 Sep 10.

PMID:
15361417
7.

Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis.

Patel RR, Subramaniam RM, Mandrekar JN, Hammack JE, Lowe VJ, Jett JR.

Mayo Clin Proc. 2008 Aug;83(8):917-22. doi: 10.4065/83.8.917.

PMID:
18674476
8.

PET scan in clinically suspected paraneoplastic neurological syndromes: a 6-year prospective study in a regional neuroscience unit.

Hadjivassiliou M, Alder SJ, Van Beek EJ, Hanney MB, Lorenz E, Rao DG, Sharrack B, Tindale WB.

Acta Neurol Scand. 2009 Mar;119(3):186-93. doi: 10.1111/j.1600-0404.2008.01089.x. Epub 2008 Oct 6.

PMID:
18855873
9.

18F-FDG-PET/CT in the diagnosis of paraneoplastic neurological syndromes: a retrospective analysis.

Bannas P, Weber C, Derlin T, Lambert J, Leypoldt F, Adam G, Mester J, Klutmann S.

Eur Radiol. 2010 Apr;20(4):923-30. doi: 10.1007/s00330-009-1606-0. Epub 2009 Sep 30.

PMID:
19789881
10.

Detection of underlying malignancy in patients with paraneoplastic neurological syndromes: comparison of 18F-FDG PET/CT and contrast-enhanced CT.

Schramm N, Rominger A, Schmidt C, Morelli JN, Schmid-Tannwald C, Meinel FG, Reiser MF, Rist C.

Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1014-24. doi: 10.1007/s00259-013-2372-4. Epub 2013 Mar 16.

PMID:
23503574
11.

Utility of F-18 FDG PET/CT in screening for paraneoplastic neurological syndromes.

Matsuhisa A, Toriihara A, Kubota K, Makino T, Mizusawa H, Shibuya H.

Clin Nucl Med. 2012 Jan;37(1):39-43. doi: 10.1097/RLU.0b013e3182393390.

PMID:
22157026
12.

Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients.

Kristensen SB, Hess S, Petersen H, Høilund-Carlsen PF.

Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):2056-63. doi: 10.1007/s00259-015-3126-2. Epub 2015 Jul 21.

PMID:
26194717
13.

18F-fluorodeoxyglucose positron emission tomography in the diagnosis of malignancy in patients with paraneoplastic neurological syndrome: a systematic review and meta-analysis.

García Vicente AM, Delgado-Bolton RC, Amo-Salas M, López-Fidalgo J, Caresia Aróztegui AP, García Garzón JR, Orcajo Rincón J, García Velloso MJ, de Arcocha Torres M, Alvárez Ruíz S; Oncology Task Force of Spanish Society of Nuclear Medicine and Molecular Imaging.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1575-1587. doi: 10.1007/s00259-017-3722-4. Epub 2017 May 27. Review.

PMID:
28550611
14.

18F-FDG PET-CT in the evaluation of paraneoplastic syndromes: experience at a regional oncology centre.

Vaidyanathan S, Pennington C, Ng CY, Poon FW, Han S.

Nucl Med Commun. 2012 Aug;33(8):872-80. doi: 10.1097/MNM.0b013e3283550237. Erratum in: Nucl Med Commun. 2012 Sep;33(9):1006.

PMID:
22669052
15.

Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.

Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.

Interact Cardiovasc Thorac Surg. 2010 Jun;10(6):1009-14. doi: 10.1510/icvts.2009.227538. Epub 2010 Mar 2.

PMID:
20197344
16.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
17.

The clinical utility of FDG PET/CT among solid organ transplant recipients suspected of malignancy or infection.

Wareham NE, Lundgren JD, Da Cunha-Bang C, Gustafsson F, Iversen M, Johannesen HH, Kjær A, Rasmussen A, Sengeløv H, Sørensen SS, Fischer BM.

Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):421-431. doi: 10.1007/s00259-016-3564-5. Epub 2016 Nov 12.

18.

The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders.

Rees JH, Hain SF, Johnson MR, Hughes RA, Costa DC, Ell PJ, Keir G, Rudge P.

Brain. 2001 Nov;124(Pt 11):2223-31.

PMID:
11673324
19.

18F-FDG PET/CT to differentiate malignant necrotic lymph node from benign cystic lesions in the neck.

Abadi P, Johansen A, Godballe C, Gerke O, Høilund-Carlsen PF, Thomassen A.

Ann Nucl Med. 2017 Feb;31(2):101-108. doi: 10.1007/s12149-016-1142-3. Epub 2016 Dec 5.

PMID:
27921286
20.

[Usefulness of (18)FDG PET-CT scan as a diagnostic tool of fever of unknown origin].

García-Gómez FJ, Acevedo-Báñez I, Martínez-Castillo R, García-Gutiérrez M, Tirado-Hospital JL, Borrego-Dorado I.

Med Clin (Barc). 2015 Jul 20;145(2):62-6. doi: 10.1016/j.medcli.2014.09.004. Epub 2014 Dec 10. Spanish.

PMID:
25500351

Supplemental Content

Support Center